High Fidelity Restriction Endonucleases
US-2024352437-A1 · Oct 24, 2024 · US
US2016333327A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016333327-A1 |
| Application number | US-201615151364-A |
| Country | US |
| Kind code | A1 |
| Filing date | May 10, 2016 |
| Priority date | May 14, 2015 |
| Publication date | Nov 17, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein is a variant pol6 polymerase having at least one mutation selected from H223, N224, Y225, H227, 1295, Y342, T343, I357, S360, L361, I363, S365, S366, Y367, P368, D417, E475, Y476, F478, K518, H527, T529, M531, N535, G539, P542, N545, Q546, A547, L549, I550, N552, G553, F558, A596, G603, A610, V615, Y622, C623, D624, I628, Y629, R632, N635, M641, A643, I644, T647, I648, T651, I652, K655, W656, D657, V658, H660, F662, L690 and combinations thereof.
Opening claim text (preview).
What is claimed is: 1 . A modified DNA polymerase having a DNA polymerase activity comprising an amino acid sequence having at least 70% sequence identity to the amino acid sequence as set forth in SEQ ID NO: 1 or 2, which amino acid sequence includes one or more amino acid substitutions selected from the group consisting of H223, N224, Y225, H227, I295, Y342, T343, I357, S360, L361, I363, S365, S366, Y367, P368, D417, E475, Y476, F478, K518, H527, T529, M531, N535, G539, P542, N545, Q546, A547, L549, I550, N552, G553, F558, A596, G603, A610, V615, Y622, C623, D624, I628, Y629, R632, N635, M641, A643, I644, T647, I648, T651, I652, K655, W656, D657, V658, H660, F662, L690, and combinations thereof. 2 . The modified DNA polymerase of claim 1 , wherein the substitutions are selected from the group consisting of H223A, N224Y/L/Q/M/R/K, Y225L/T/I/F/A/M, H227P/E/F/Y, I295 W/F/M/E, Y342L/F, T343N/F, I357G/L/Q/H/W/M/A/E/Y/P, S360G/E/Y, L361M/W/V/F, I363V/A/R/M/W, S365Q/W/M/A/G, S366A/L, Y367L/E/M/P/N/F, P368G, D417P, E475D, Y476V, F478L, K518Q, H527 W/R/L/Y/T/M, T529M/F, M531H/Y/A/K/R/W/T/L/V/G, N535L/Y/M/K/I/R/W/Q, G539Y/F, P542E/S/G, N545K/D/S/L/R/Q/W, Q546 W/F, A547M/Y/W/F/V/S, L549Q/Y/H/G/R/K, I550A/W/T/G/F/S, N552L/M/S/T, G553S/T/E/Q/K/R/M, F558P/T, A596S, G603T/A/L, A610T/E, V615A/T, Y622A/M, C623G/S/Y/F, D624F/K, I628Y/V/F/L/M, Y629 W/H/M/K, R632L/C, N635D, M641L/Y, A643L, I644H/M/Y, T647G/A/E/K/S/Y, I648K/R/V/N/T/L, T651Y/F/M, I652Q/G/S/N/F/T/A/L/E/K/M, K655G/F/E/N/Q/M/A, W656E, D657R/P/A/E, V658L, H660A/Y, F662I/L, L690M and combinations thereof. 3 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has an altered characteristic as compared to the parental polymerase. 4 . The modified DNA polymerase of claim 3 , wherein the altered characteristic is selected from fidelity, processivity, elongation rate, stability, solubility and the ability to bind and/or incorporate polyphosphate nucleotides such as a tetraphosphate, pentaphosphate, hexaphosphate, heptaphosphate or octophosphate nucleotide. 5 . The modified DNA polymerase of claim 3 , wherein the altered characteristic is the ability to incorporate a nucleotide polyphosphate having 4, 5, 6, 7 or 8 phosphates into a growing DNA strand. 6 . The modified DNA polymerase of claim 5 , wherein the nucleotide polyphosphate is tagged. 7 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to S366A/L. 8 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to E475D. 9 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to F478L. 10 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to K518Q. 11 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to T529M. 12 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to N535L. 13 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to N545K/L. 14 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to A547F. 15 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to G553S. 16 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to T647G/Y. 17 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to T651Y. 18 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to I652Q/A/L/E/K/M. 19 . The modified DNA polymerase of claim 1 selected from H223A; N224Y/L/Q/M/R/K; Y225L/1/T/F/A/M; H227P/E/F/Y; I295F/E/M/W; Y342L/F; T343N/F; I357G/L/Q/H/W/M/A/E/Y/P; S360G/E/Y; L361M/W/V/F; I363V/A/R/M/W; S365Q/W/M/A/G; S366A/L; Y367L/E/M/P/N/F; P368G; D417P; E475D; Y476V; F478L; K518Q; H527W/R/L/Y/T/M; T529M/F; M531H/Y/A/K/R/W/T/L/V/G; N535L/Y/M/K/I/R/W/Q; P542E/S/G; N545D/K/S/L/R/Q/W; Q546 W/F; A547F/M/W/Y/V/S; L549H/Y/Q/G/R/K; I550A/W; I550T/G/F/S; N552L/M/T; G553S/T/E/Q/K/R/M; F558P/T; A596S; G603T/A/L; A610T/E; V615A/T; Y622A/M; C623G/S/Y/A/F; D624F/K; I628Y/V/F/L/M; Y629 W/H/M/K; R632L/C; N635D; M641 L/Y; A643L; I644H/M/Y; T647G/A/E/K/S/Y; I648K/R/V/N/T/L; T651Y/F/M; I652Q/G/S/N/F/T/A/L/E/K/M; K655G/F/E/N/Q/M/A; W656E; D657R/P/A/E; V658L; H660A/Y; F662I/L; L690M; S366A+N535L; T651Y+N535L; Y342L+E475D+F478L; T343N+D417P+K518Q; N535L+N545K+T651Y; I363V+E475D+Y476V; S366L+G553S+F558P; S366A+N535L+A547M; S366A+P542E+N545K; S366A+P542E+I652Q; S366A+N535L+T529M; S366A+N535L+I652Q; S366A+N535L+N545K; T651 Y+P542E+N545K; T651Y+P542E+Q546 W; T651Y+P542E+S366A; T651 Y+N535L+N545K; S366A+N535I+I652Q; T651Y+S366A+A547F; T647G+A547F+Y225T; A547F+A610T+S366A; A547F+A610T+Y225I; S366A+T647G+A547F; T529M+S366A+A547F; T647E+S366A+A547F; T529M+T647G+A547F; N545K+S366A+A547F; T647G+A547F+T529M; T529M+A610T+A547F; M641 Y+T529M+A547F; T647G+C623G+A547F; A610T+I295 W+T651Y; V615A+M531Y+T647G; S366 L+F478L+A596S+L690M; H223A+G553S+A643 L+F662I; N535L+N545K+T651Y+T529M; N535L+N545K+T651Y+N635D; N535L+N545K+T651 Y+I652Q; S366A+N535L+I652Q+T529M; S366A+S365A+P368G+G603T; N535L+N545K+T651Y+T647G; S366A+N535L+I652Q+A547Y; S366A+N535L+A547M+T647G; T529M+S366A+A547F+N545K; T529M+S366A+A547F+N545R; T529M+S366A+A547F+N552L; T529M+S366A+A547F+Y629 W; N535I+N545K+T651Y+T529M; N535I+N545K+T651 Y+N635D; N535I+N545K+T651 Y+I652Q; N535L+N545K+T651Y+T647G+C623G; N535L+N545K+T651 Y+T647G+I628Y; S366A+N535L+A547M+T647G+S360G; N535I+N545K+T651 Y+I652Q+Y225I; N535L+N545K+T651Y+T647G+K655G; N535L+N545K+T651Y+T647G+L549Q; S366A+N535L+I652Q+A547Y+K655G; T529M+S366A+A547F+N545L+Y629 W; T529M+S366A+A547F+N545L+Y225L; T529M+S366A+A547F+N545L+Y225F; T529M+S366A+A547F+N545L+K655F; T529M+S366A+A547F+N545L+N552L; T529M+S366A+A547F+N545R+M531A; T529M+S366A+A547F+N545R+G539Y; T529M+S366A+A547F+N545R+V658L; T529M+S366A+A547F+N545L+Y225L+D657R; T529M+S366A+A547F+N545L+Y225L+N552L; T529M+S366A+A547F+N545L+Y225L+I652G; T529M+S366A+A547F+N545L+Y225L+I652Q; T529M+S366A+A547F+N545L+Y225L+N552M T529M+S366A+A547F+N545L+Y225L+D657R+N224R; T529M+S366A+A547F+N545L+Y225L+D657R+I628M; T529M+S366A+A547F+N545L+Y225L+D657R+K655A; and T529M+S366A+A547F+N545L+Y225L+D657R+Y629 W. 20 . The modified DNA polymerase of claim 1 comprising S366A+T529M+N545L+A547F. 21 . The modified DNA polymerase of claim 20 further comprising at least one mutation selected from a. Y225L/F/A/M; b. M531A/G; c. G539Y; d. N552L/T; e. Y629 W/K; f. K655F/Q/M/A; and g. D657R/E/P/A. 22 . The modified DNA polymerase of claim 1 comprising S365A+S366A+P368G+G603T. 23 . The modified DNA polymerase of claim 1 , wherein said polymerase comprises less than 10 mutations.
DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title
DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title
Nucleotidyltransferases (2.7.7) · CPC title
Nucleotidyltransferases (2.7.7) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.